TRPA1通过激活由SRXN1介导的内质网膜应激来加剧骨质结晶和骨质疏松症
Pengfei Zhu1, Huaqiang Tao1, Kai Chen2
1Department of Orthopaedics, First Affiliated Hospital of Soochow University, Suzhou, 215006, Jiangsu, China.
Cell death & disease
|August 27, 2024
概括
暂时受体潜在氨酸1 (TRPA1) 抑制降低骨质细胞分化和内质网膜压力,为骨质疏松症提供了潜在的新治疗方法. 这项研究揭示了TRPA1.
科学领域:
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
- 骨生物学 骨生物学 骨生物学
背景情况:
- 骨质疏松症 (OP) 涉及不平衡的骨重塑,过度的骨质细胞活动是关键因素.
- 暂时受体潜在蛋白1 (TRPA1) 以其在疼痛和软骨中的作用而闻名,但其在OP中的功能尚未得到研究.
- 准骨质细胞生成是OP治疗的一个有前途的策略.
研究的目的:
- 调查TRPA1在骨质细胞形成和骨质疏松症中的作用和治疗潜力.
- 阐明TRPA1在骨重塑中的功能背后的分子机制.
主要方法:
- 在骨质细胞分化过程中的TRPA1表达分析.
- 药理学和基因抑制TRPA1 (使用siRNA和HC030031).
- 评估骨质细胞标记物,内分泌网膜 (ER) 应激通路 (PERK),活性氧物种 (ROS) 和抗氧化基因SRXN1.1.
- 在体内研究中,使用被卵巢切除的小鼠,通过腺相关病毒-9 (AAV-9) 在巨细胞中对TRPA1进行敲除.
主要成果:
- 在骨质细胞分化过程中,TRPA1的表达增加.
- 抑制TRPA1显著减少骨质细胞形成,特征性基因表达,并通过PERK途径抑制ER压力.
- TRPA1对ROS进行负调节,对抗氧化基因SRXN1进行正调节;SRXN1的抑制增强了骨质细胞形成和ER压力.
- 在巨细胞中降低TRPA1,改善了骨质细胞分化和骨质疏松症在体内.
结论:
- 沉默TRPA1通过通过ROS介导的PERK通路的抑制来降低ER压力的调节来抑制骨质细胞分化.
- TRPA1成为骨质疏松症治疗的潜在治疗点.
相关概念视频
Osteoclasts in Bone Remodeling
2.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.9K
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
Bone Remodeling
38.2K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.2K
Enzyme-linked Receptors
77.7K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
77.7K
Role of ER in the Secretory Pathway
5.3K
Eukaryotic cells have a special pathway that enables communication between various intracellular membrane-bound compartments and also with the extracellular environment. This pathway is termed as the secretory pathway.
Components of the secretory pathway
About a third of proteins synthesized in the cell are sorted via the secretory route. They shuffle between different compartments in membrane-bound vesicles until they reach their final destination. The main intracellular compartments involved...
Components of the secretory pathway
About a third of proteins synthesized in the cell are sorted via the secretory route. They shuffle between different compartments in membrane-bound vesicles until they reach their final destination. The main intracellular compartments involved...
5.3K
The Unfolded Protein Response
4.5K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.5K


